IR-MED's AI-Powered Infra-Red Spectrographic Decision

IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually...

Related Keywords

Israel ,Israeli ,Oded Bashan ,Rosh Pina ,Petah Tikva ,Yaniv Cohen ,Sharon Levkoviz ,Rabin Medical Center ,Company Annual Report On Form ,Beit Rivka Hospital ,Science Officer ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Chief Financial ,Other Otc Irme ,Vr Med ,Nc ,R Med Inc ,Tcqb Irme ,Non Invasive Device ,Ressuresure ,Healthcare Profession ,